Follow
Kelsey A Carpenter
Kelsey A Carpenter
Postdoctoral fellow, Van Andel Institute
Verified email at vai.org
Title
Cited by
Cited by
Year
Sclerostin Antibody Treatment Increases Bone Mass and Normalizes Circulating Phosphate Levels in Growing Hyp Mice
KA Carpenter, RD Ross
Journal of Bone and Mineral Research 35 (3), 596-607, 2020
272020
Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice
KA Carpenter, R Davison, S Shakthivel, KD Anderson, FC Ko, RD Ross
Bone 154, 116201, 2022
112022
Bone quality in relation to HIV and antiretroviral drugs
AZ Olali, KA Carpenter, M Myers, A Sharma, MT Yin, L Al-Harthi, RD Ross
Current HIV/AIDS Reports 19 (5), 312-327, 2022
82022
Wnt regulation of hematopoietic stem cell development and disease
KA Carpenter, KE Thurlow, SEL Craig, S Grainger
Current topics in developmental biology 153, 255-279, 2023
12023
Flip or Flop: Do Students Thrive in a Flipped Classroom?
KA Carpenter, JM Williams, C Ferrigno
The FASEB Journal 34 (S1), 1-1, 2020
12020
A test of the (hu) MANid sex and ancestry estimation program on a diverse sample of modern, historic, and prehistoric mandibles
PA Lynch, KA Carpenter, MW Kenyhercz, HM Garvin
AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY 165, 163-163, 2018
12018
The anti-HIV drug abacavir stimulates β-catenin activity in osteoblast lineage cells
AZ Olali, J Wallace, H Gonzalez, KA Carpenter, N Patel, LC Winchester, ...
JBMR plus 8 (5), ziae037, 2024
2024
EGFR-dependent endocytosis of Wnt9a and Fzd9b promotes β-catenin signaling during hematopoietic stem cell development in zebrafish
N Nguyen, KA Carpenter, J Ensing, C Gilliland, EJ Rudisel, EM Mu, ...
Science Signaling 17 (832), eadf4299, 2024
2024
Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-linked hypophosphatemia (XLH)
KA Carpenter, DO Alkhatib, BA Dulion, E Guirado, S Patel, Y Chen, ...
International Journal of Oral Science 15 (1), 47, 2023
2023
Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-Linked Hypophosphatemia (XLH)
R Ross, K Carpenter, D Alkhatib, B Dulion, E Guirado, S Patel, Y Chen, ...
Research Square, 2023
2023
EGFR-initiated endocytosis of Wnt9a and Fzd9b is required for β-catenin signaling
N Nguyen, KA Carpenter, KE Thurlow, E Mu, C Gilliland, S Grainger
bioRxiv, 2022.09. 25.509379, 2022
2022
Regulation of FGF23 by Sclerostin is independent of canonical Wnt-signaling in the HypxHBM mouse model
K Carpenter, R Ross
JOURNAL OF BONE AND MINERAL RESEARCH 37, 220-220, 2022
2022
Osteocyte Regulation of FGF23 by Sclerostin in the Disease Model of X-Linked Hypophosphatemia
KA Carpenter
Rush University, 2022
2022
Sclerostin-antibody Effect on Dental Pathologies in Hyp Mice
K Carpenter, E Guirado, Y Chen, A George, R Ross
JOURNAL OF BONE AND MINERAL RESEARCH 35, 302-302, 2020
2020
High Bone Mass Phenotype is Present as Early as 8 weeks in CFW Mice
M Moran, K Carpenter, B Wilson, A Palmer, DR Sumner
JOURNAL OF BONE AND MINERAL RESEARCH 33, 363-363, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–15